Patrick A Mayes insider trades: Incyte (INCY) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Patrick reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | INCY | ↓ Sell | 2,207 | $123.99 | $274K | Direct | Aug 7, 2026 (2d) |
| Aug 3, 2026 | INCY | ↓ Sell | 47,954 | $119.58 | $5.7M | Direct | Aug 4, 2026 (1d) |
| Dec 11, 2025 | INCY | ↓ Sell | 5,808 | $95.55 | $555K | Direct | Dec 12, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INCY insiders
Open-market trades in the last 12 months
About Patrick A Mayes's insider trades
Patrick A Mayes is EVP & Chief Scientific Officer at Incyte (INCY). Since Dec 11, 2025, Patrick has reported no open-market purchases and 3 sales worth $6.6M on SEC Form 4. In the last 12 months: 3 sales ($6.6M).
Their filings also include shares withheld for taxes (3 filings), option exercises (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INCY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.